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Objective. Autoimmune-prone B-cell activating factor transgenic mice, a mouse model of systemic lupus
erythematosus and Sjögren's syndrome exhibit neuroinflammation, anxiety-like phenotype, deficit in adult
hippocampal neurogenesis and impaired neurogenesis-dependent and neurogenesis-independent dentate
gyrus long-term potentiation. Given that n−3 polyunsaturated fatty acids regulate hippocampal plasticity
and inflammatory responses, we investigated whether n−3 polyunsaturated fatty acids-enriched diet
might prevent age-dependent hippocampal changes in B-cell activating factor transgenic mice.
Methods. B-cell activating factor transgenic mice were fed for 12 weeks with either n−3 polyunsaturated
fatty acids-enriched or control diet and we tested the effect of this dietary supplementation on hippocampal
inflammation, progenitor cell proliferation and neurogenesis-dependent and neurogenesis-independent
long-term potentiation.
Results. Dietary supplementation with n−-3 polyunsaturated fatty acids significantly decreased hippo-
campal microglial activation and increased the density of bromodeoxyuridine and doublecortin-positive
newly-formed cells in the subventricular zone of hippocampus. Furthermore, B-cell activating factor trans-
genic mice fed with n-3 polyunsaturated fatty acids-enriched diet displayed normal long-term potentiation
at the medial perforant pathway/dentate gyrus connections.
Conclusions. The results indicate that n-3 fatty acids prevent neuroinflammation and deficits of hippocam-
pal plasticity in B-cell activating factor transgenic mice and suggest that increased n-3 fatty acids intake
might represent a potential therapeutic option to prevent neuropsychiatric symptoms associated with auto-
immune diseases.© 2011 Elsevier Inc. All rights reserved.Introduction
Systemic lupus erythematosus (SLE) and Sjögren's syndrome
(SjS) are prototypic autoimmune diseases characterized by a loss
of immunologic tolerance, production of auto-antibodies and in-
flammation eventually leading to multiple organ damage (Croker
and Kimberly, 2005). Several cytokines have been involved in the
pathogenesis of these disorders. B-cell activating factor (BAFF) is a
powerful modulator of B-cell activity (Mackay and Schneider,
2009). BAFF blood levels are increased in patients with autoimmune
diseases such as SLE and SjS and the neutralization of this cytokineiatric Medicine (NYCPM), De-
reet, Room 509, New York, NY
rights reserved.is now a promising approach to prevent the development of these
conditions (Melchers, 2003). BAFF transgenic (Tg) mice develop an
SLE and secondary SjS-like phenotype (Mackay et al., 1999)
(Groom et al., 2002). Furthermore, BAFF Tg mice exhibit age-
dependent abnormal emotional behavior associated with brain in-
flammation, decreased adult hippocampal neurogenesis and dentate
gyrus (DG) deficit in neurogenesis-dependent and neurogenesis-
independent long-term potentiation (LTP) (Crupi et al., 2010).
Given that antidepressant treatments modulate hippocampal plas-
ticity and neuroinflammation (Krishnan and Nestler, 2010)
(Bianchi et al., 1994; Mackay et al., 2009; Chung et al., 2011), it is
likely that new therapeutic treatments for neuropsychiatric symp-
toms associated with autoimmune diseases might affect these hip-
pocampal biomarkers in BAFF Tg mice.
Consumption of n−3 polyunsaturated fatty acids (n−3 PUFAs)
modulates inflammation, neurogenesis and hippocampal plasticity
S104 R. Crupi et al. / Preventive Medicine 54 (2012) S103–S108making these fatty acids attractive candidates for prevention and
amelioration of neuropsychiatric symptoms of several autoimmune
diseases (Ma et al., 2008; Robson et al., 2008; Yamashima, 2008; He
et al., 2009; Kashiyae et al., 2009; Venna et al., 2009; Ma et al.,
2010; Osumi, 2010). Furthermore, it has been proposed that dietary
factors may contribute to the etiology and progression SLE and SjS
syndrome, and that nutritional intervention may modify the severity
of pathological abnormalities (Lefkowith and Klahr, 1996;
Simopoulos, 2002; Cermak et al., 2003; Pestka, 2010). A previous re-
port indicates that n−3 PUFA-supplemented diet has positive effects
on autoimmune-prone NZB/W female mice by regulating the activity
of antioxidant enzymes (Bhattacharya et al., 2003). To date, there are
no studies that explored the role of n−3 PUFA on hippocampal pro-
genitor cell proliferation and synaptic plasticity in BAFF Tg mice.
The present study was designed to determine whether a diet sup-
plemented with n−3 fatty acid leads to prevention or attenuation of
age-dependent hippocampal abnormalities in BAFF Tg mice. There-
fore, we investigated the effects of the interventions on hippocampal
inflammation, progenitor cell proliferation and DG LTP.
Materials and methods
Animals
8 week-old BAFF Tg and wild-type (WT) mice on a C57BL/6 background
(Mackay et al., 1999) were used in the experiments. Mice were kindly pro-
vided by Dr. Linda Spatz at CCNY and were maintained under 12:12 light–
dark cycle in a temperature (21 °C±1 °C) and humidity (50%±5%) con-
trolled room. All procedures were approved by the Institutional Laboratory
Animal Care and Use Committee at the City College of New York.
Prior to study commencement, both WT and BAFF Tg had free access to a
standard rodent chow. At beginning of the study, (8 week-old mice, prior to
the appearance of the behavioral and hippocampal abnormalities) mice were
provided with 12 weeks ad libitum access to control diet or diet supplemented
with PUFA. PUFA-supplemented diet contained both n−6 and n−3 PUFA
whereas control diet lacked n−3 PUFA (Table 1). Mice were randomized
into 3 groups: group 1, WT treated with control diet, group 2, BAFF Tg treated
with control diet; group 3, BAFF Tg treatedwith n−3 PUFA-supplemented diet.
Diets
N−3 PUFA-enriched and control diets were prepared by Harlan Tekland
(Madison, WI) and were stored in vacuum bags to reduce PUFA oxidation.
The fatty acid composition of the diets is presented in Table 1. As previously
reported, this n−3 PUFA-supplemented diet modulates emotional behav-
iors, neurogenesis and synaptic plasticity in mice (Venna et al., 2009).
CD68 immunostaining
CD68 is a marker of neuroinflammation (activated microglia). Tissue sec-
tions (40 μm) were processed using a previously described immunohisto-
chemical procedure (Grider et al., 2006). An unbiased, semi-quantitative
analysis of the diaminobenzidine (DAB) stained cells in the hippocampus
was then performed using ImageJ program (National Institute of Health,Table 1
Fatty acid composition (%) of control and n−3 PUFA-enriched diet. New York, USA,
2009.
Fatty acids n−3 PUFA diet Control diet
C16:0 palmitic 0.63 2.10
C18:0 stearic 0.21 0.70
C18:1 ω9 oleic 3.15 2.31
C18:2 ω6 linoleic 1.61 1.89
C18:3 ω3 alpha-linolenic 0.70 0.0
C18:3 ω6 gamma-linolenic 0.21 0.0
C18:4 ω3 stearidonic 0.14 0.0
C20:4 ω6 arachidonic 0.035 0.0
C20:5 ω3 eicosapentaenoic 0.35 0.0
C22:6 ω3 docosahexaenoic 0.14 0.0Bethesda, MA, USA). Three fields (CA1, CA3 and DG) were randomly captured
in each image. The measurements obtained in each hippocampal regions
were averaged to obtain an estimate of hippocampal inflammatory response.
In each animal, three consecutive slides (starting from brain slices at the
levels of Bregma—0.82 mm) were stained and analyzed. Data are expressed
as number of particle/area±SE (Crupi et al., 2010).
Hippocampal progenitor cell proliferation
To investigate the effect of n−3 PUFA-supplemented diet on hippocam-
pal adult neurogenesis, the incorporation of thymidine analogue 5-bromo-
2′-deoxyuridine (BrdU) in proliferating cells was evaluated. Mice were
administered intraperitoneally with 150 mg/kg BrdU dissolved in saline
(Sigma-Aldrich, St. Louis, MO, USA). Two hours after the injection, mice
were anesthetized with sodium pentobarbital (30 mg/kg, Sigma-Aldrich, St.
Louis, MO, USA), sacrificed and transcardially perfused with ice cold 0.1-
mol/L PBS (pH 7.4), followed by ice cold 4% paraformaldehyde in 0.1-mol/
L PB. 35 μm thick brains slices were collected for immunocytochemistry
through the entire hippocampus. The staining was visualized with DAB.
Briefly, sections were boiled in citric acid (pH 6.0) for 5 min, rinsed with PBS,
treated with 0.01% trypsin in Tris/CaCl2 for 10 min, incubated for 30 min
with 2 N HCl and blocked with 5% NGS. Sections were first incubated
overnight with anti-mouse BrdU (1:100) and then were incubated for 1 h
with secondary antibody (1:200 biotinylated goat anti-mouse). Sections were
developed using the DAB kit (Vector, CA, USA). BrdU labeling was quantified
according to a method previously described (Malberg et al., 2000).
Doublecortin staining
For Doublecortin (DCX) staining sections were rinsed in PBS, treated with
1% H2O2 in 1:1 PBS and methanol, incubated in 10% normal donkey serum
and 0.3% Triton X-100 for 30 min, incubated overnight at 4 °C in primary an-
tibody for doublecortin (goat; 1:500; Santa Cruz Biotechnology, Santa Cruz,
CA, USA). The secondary antibody was biotinylated donkey anti-goat
(1:500) (Jackson ImmunoResearch, PA, USA) DCX+ cells were subcategor-
ized according to their dendritic morphology: DCX+ cells with no tertiary
dendritic processes and DCX+ cells with complex, tertiary dendrites. Sholl
analysis was performed on DCX+ cells with tertiary dendrites (n=10 cells
per brain) using Neurolucida (Microbrightfield, Williston, Vermont) and
the dendritic length and number of intersections used were calculated
using NeuroExplorer (Microbrightfield, Williston, Vermont). All samples
were number coded, and analysis was done blind to genotype (Wang et al.,
2008). Images were collected with a Zeiss (Oberkochen, Germany)
Axioplan-2 upright microscope.
Electrophysiology
Transverse hippocampal slices were prepared fromWT and BAFF Tg mice
and maintained in an interface chamber at 32 °C and perfused with oxygen-
ated artificial cerebrospinal fluid containing 119 mM NaCl, 2.3 mM KCl,
1.3 mM MgSO4, 2.5 mM CaCl2, 26.2 mM NaHCO3, 1 mM NaH2PO4, and
11 mM glucose. Slices were allowed to equilibrate for 2 h before recording.
The medial perforant pathway (MPP) was identified by assessing paired-
pulse inhibition of the MPP/DG synaptic connection. Field excitatory postsyn-
aptic potentials (fEPSP) were recorded in the molecular layer above the
upper blade of the DG by using a glass capillary microelectrode filled with ar-
tificial cerebrospinal fluid (tip resistance 1–3 MΩ). Basal synaptic transmis-
sion was monitored every 30 s with a stimulus intensity that produced a
third maximal response. Neurogenesis-dependent long-term potentiation
(artificial cerebrospinal fluid [ACSF]-LTP) was induced with four trains of
1 s each, 100 Hz within the train, repeated every 15 s. Neurogenesis-
dependent LTP was induced in the presence of 50 μmol/L picrotoxin
(Sigma, St. Louis, Missouri) in the artificial cerebrospinal fluid (PICRO-LTP).
Responses were recorded every minute for 60 min after LTP induction
(Crupi et al., 2010).
Data analysis
All values are expressed as mean±standard (S.E.M.). The results were
analyzed by analysis of variance (ANOVA), followed by a Fisher's post-hoc
test. The level of significance was set to Pb0.05.
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Neuroinflammation
To investigate the mouse genotype effect on hippocampal neu-
roinflammation, CD68 number of particle/area in WT and BAFF Tg
mice fed with control diet were compared. The results confirm our
earlier report and indicate an age-dependent development on hippo-
campal inflammation in BAFF Tg mice (F(1,8)=27.4, P=0.012). n−3
PUFA prevented the development of microglial proinflammatory re-
action in BAFF Tg mice (F(1,8)=4.3, P=0.4). (Figs. 1A and B).
Progenitor cell proliferation
Progenitor cell proliferation was assessed by using BrdU and DCX
immunohistochemistry (Figs. 2A, B). BrdU is incorporated into the
DNA of proliferating cells in the S phase of the mitotic cycle and se-
lectively labels dividing cell. Stereological analysis revealed that
there was a significant decrease in the number of BrdU+ cells in
the DG sections from BAFF Tg mice treated with control diet com-
pared with WT mice (WT-control: 2,211.3±43.3; BAFF Tg-control:
2,005.7±38.4, F(1,8)=24.8, P=0.001). On the contrary, n−3
PUFA-supplemented diet increased the number of BrdU+ cells in
the granule cell layer (GCL) and prevented age-dependent deficit
in progenitor cell proliferation in BAFF Tg mice (BAFF Tg-PUFA:
2,159.6±40.5, F(1,8)=3.5, P=0.1) (Fig. 2B).
Furthermore, ANOVA revealed that BAFF Tg mice fed with control
diet showed a decreased number of total DCX+ cell (WT-control:
2,454.2±47.5; BAFF Tg-control: 2,231.6±50.3, F(1,8)=12.4,
P=0.01). n−3 PUFA-supplemented diet prevented this age-
dependent deficit (BAFF Tg-PUFA: 2,553.5±42.7, P>0.05) (Fig. 2C).
Neurogenesis-dependent and independent LTP in MPP/DG connections
To study basal synaptic transmission and LTP in hippocampus a
series of electrophysiological recordings in hippocampal slices were
obtained from WT and BAFF Tg mice. fEPSPs were obtained stimulat-
ing the MPP and recording in GCL in DG. To determine the effects of
diets on basal synaptic transmission we first plotted fEPSP slopesFig. 1. N−3 PUFA-supplemented diet decreases hippocampal inflammation in BAFF Tg mi
mice fed with control diet showed increased anti-CD68 positive cells in hippocampus. N−
Data shown represent the mean±SEM. n=5 for each group. Scale bar=100 μm. ⁎Pb0.05.against various stimulation intensities. No significant differences in
input–output curves were obtained between groups (P>0.05). Simi-
larly, no between group differences in PPI were observed (P>0.05)
(Figs. 3A and B).
Next the neurogenesis-independent LTPwas examined. This form of
DG LTP is obtained in the presence of the γ-aminobutyric acid (GABA)
antagonist Picrotoxin (PICRO) and is induced when GABAergic inputs
to mature granule cells are inhibited. BAFF Tg-control mice showed a
significant deficit in PICRO-LTP. The amount of LTP obtained 60 min
after tetanus was 165.6±8.8% in WT-Control mice and 134.2±6.4% in
BAFF Tg-Controlmice (F(1,8)=18.2, Pb0.01). n−3 PUFA-supplemented
diet prevented this deficit (BAFF Tg-PUFA: 161.3±6.98%, 60 min after
tetanus (F(1,8)=4.1, P=0.2) (Fig. 3C).
Tetanic stimulation of the MPP/DG path in the absence of Picro-
toxin elicits a weak LTP that is based on the newly generated neurons
(ACSF-LTP). In BAFF Tg-control mice this neurogenesis-dependent
LTP was disrupted (WT-control: 126.1±6.1%; BAFF Tg-control:
104.03±7.9%, 60 min after tetanus (F(1,8)=22.8, P=0.0001). N−3
PUFA-supplemented diet prevented this deficit (BAFF Tg-PUFA:
125.4±6.8%; F(1,8)=2.7, P=0.3).
These results indicate that n−3 PUFA supplementation restores
normal synaptic plasticity in both mature and newly generated neu-
rons in BAFF Tg mice.
Discussion
In this study, we investigated the effects of n−3 PUFA-supple-
mented diet on hippocampal inflammation, adult neurogenesis and
synaptic plasticity impairment in BAFF Tg mice. Our results show
that BAFF Tg mice treated with control diet display hippocampal
microglia activation, decreased progenitor cell proliferation and DG
LTP. N−3 PUFA supplementation prevented these hippocampal
abnormalities.
n−3 PUFA supplementation inhibits proinflammatory responses
in hippocampus in BAFF Tg mice. Given the epidemiological and clin-
ical data linking n−3 PUFAs deficiency with mood disorders (Parker
et al., 2006), autoimmune diseases (Fernandes et al., 2008) and ab-
normal synaptic plasticity (Lafourcade et al., 2011), it is likely that n
−3 PUFA may play a pivotal role in treating autoimmune diseasece. (A) Photomicrographs showing hippocampal immunostaining with CD68. BAFF Tg
3 PUFA-supplemented diet prevented the development of hippocampal inflammation.
New York, USA, 2009.
Fig. 2. N−3 PUFA-supplemented diet restores normal hippocampal progenitor cell proliferation in BAFF Tg mice. (A) Representative photomicrographs of BrdU+ labelled cells in
dentate gyrus. (B) The number of BrdU+ labelled cells and (C) the total number of DCX+ cells were significantly increased in BAFF Tg mice fed with N−3 PUFA-supplemented diet.
Scale bar 100 μm. The results are mean±S.E.M, n=5 each group **Pb0.01. New York, USA, 2009.
Fig. 3. N−3 PUFA-supplemented diet restores normal dentate gyrus LTP in BAFF Tg mice. (A) BAFF Tg showed similar field input–output relations and paired-pulse depres-
sion (B) in the MPP/DG connection compared with age-matched WT (P>0.05). BAFF overexpression alters DG LTP. (C) MPP/DG PICRO-LTP in WT and transgenic mice.
(D) MPP/DG ACSF-LTP in WT and transgenic mice. Arrow indicates the delivery of the 100 Hz stimulation. N=5 each group. Error bars represent±1 SEM. ⁎⁎Pb0.01.
New York, USA, 2009.
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Fig. 4. Schematic representation of the effect of N−3 PUFA on dentate gyrus plasticity in BAFF Tg mice. Under physiologic condition newly generated granule cells (depicted in red)
in the adult hippocampal Dentate Gyrus (DG) became mature neurons (depicted in blue) and functionally integrate into circuits. In BAFF Tg mice inflammation reduced the number
of newly generated neuron and decrease synaptic plasticity at the Medial Perforant Pathway (MPP)-DG. N−3 PUFA-enriched diet reduces DG inflammation and restores normal
neurogenesis and neurogenesis-dependent MPP-DG synaptic plasticity. New York, USA, 2009.
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BAFF Tg mice display abnormal hippocampal progenitor cell prolifer-
ation (Crupi et al., 2010). n−3 PUFA supplementation prevented this
deficit. Our results are consistent with previous observations that
showed beneficial effect of n−3 PUFA on neurogenesis. For instance,
the number of BrdU-positive dividing cells is significantly higher in
the hippocampus of fat-1 transgenic mice compared to WT litter-
mates (He et al., 2009). The fat-1 mouse is a transgenic model rich
in endogenous n−3 fatty acids; furthermore, similar results have
also been reported with dietary supplementation (Kawakita et al.,
2006) (Beltz et al., 2007) (Venna et al., 2009). The mechanisms by
which n−3 PUFA exert modulatory effect on DG neurogenesis need
to be identified. It is likely that n−3 PUFA may influence neurogen-
esis through multiple mechanisms. In particular, it has been shown
that n−3 PUFA regulates neural stem cell proliferation and differen-
tiation (Wada et al., 2006) through increased expression level of basic
helix-loop-helix (bHLH) transcription factors promoting cell cycle
exit (Katakura et al., 2009). In addition, n−3 PUFA-enriched diet pro-
motes hippocampal plasticity and over-expression of both synapto-
physin and Brain-Derived Neurotrophic Factor (BDNF) (Venna et al.,
2009). Several lines of evidence support the involvement of BDNF in
preventing neurogenesis abnormalities in BAFF Tg mice given that
this trophic factor has been associated with increased proliferation
of newborn neurons in the adult hippocampus (Li et al., 2008) and
modulation of hippocampal morphological and functional plasticity
(Alonso et al., 2004). Neuroinflammation exerts well-known detri-
mental effects on new neurons morphology and electrophysiology
(Monje et al., 2003) (Wood et al., 2011). It is thus conceivable that
the beneficial effect of n−3 PUFA on neurogenesis in BAFF Tg mice
may be due to anti-inflammatory effects (Bazan, 2006) (Marcheselli
et al., 2003). Inflammatory blockade induces a broad spectrum of ef-
fects that could modulate neurogenesis in several ways. The decrease
in proinflammatory cytokines and attenuation of HPA axis activity
and serum glucocorticoid levels (Gould et al., 1997) (Delarue et al.,
2006) (Navarro et al., 2011) may contribute to restore normal pro-
genitor cell proliferation.
Our data showed that n−3 PUFA dietary supplementation pre-
vented decrease in DG neurogenesis-dependent and neurogenesis-
independent LTP in BAFF Tg mice. These results are consisted with
previous reports that showed a positive effect of n−3 PUFA on age-
related decrease in LTP in rodents (McGahon et al. (1997, 1999a, b)
(Kotani et al., 2003) (Kashiyae et al., 2009). Neurogenesis-dependent LTP occurs at the MPP/DG synapses and depends on
young adult-born neurons (Saxe et al., 2006). Our data indicate that,
as previously reported, increasing the number of adult-born neurons
is sufficient to enhance this form of LTP (Saxe et al., 2006) (Wang et
al., 2008) (Sahay et al., 2011). Our PUFA treatment reversed also the
impairment of MPP/DG LTP recorded in the presence of picrotoxin.
This form of LTP depends upon mature granule neurons synaptic ac-
tivity (Saxe et al., 2006). The modulation of PICRO-LTP might be due
to the blockage of hippocampal microglia activation as previously
reported in different animal models (Calon et al., 2005) (Green et
al., 2007) (Fig. 4). Furthermore, n−3 PUFA supplementation might
regulate PICRO-LTP through effects on membrane fluidity, receptor
binding proteins, AMPA receptor activation (McGahon et al., 1999a)
(Lu et al., 2001) (Martin et al., 2002) and on calcium homeostasis
(Kashiyae et al., 2009).
Conclusions
Overall, the results from the present study suggest that n−3
PUFA-supplemented diet prevents age-dependent deficit in hippo-
campal plasticity in BAFF Tg mice. Future studies are needed to iden-
tify the mechanisms regulating these effects and to probe whether
these plastic changes contribute to behaviors.
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